# FDA 483 - Celltrion Inc. - October 22, 2019

Source: https://www.keypedia.com/records/483/celltrion-inc/57f6ed48-3c6c-4460-80ee-647bd64b5189

> FDA 483 for Celltrion Inc. on October 22, 2019. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Celltrion Inc.
- Inspection Date: 2019-10-22
- Product Type: drugs
- Office Name: Office of Biological Products Operations - Division I
- Summary: An FDA inspection of Celltrion Inc., a sterile pharmaceutical manufacturer in Incheon, Korea, revealed a significant deficiency in aseptic processing areas. The firm's dynamic airflow visualization studies for its restricted access barrier system were found to be inadequate, failing to properly visualize airflow at critical areas during simulated interventions. This indicates a potential risk to the sterility of parenteral drug products.

## Related Documents

- [CRL - Unknown Date](https://www.keypedia.com/records/crl/celltrion-inc/852dfc18-c5b9-4e7b-a308-3f9183dd0a6c)
- [CRL - Unknown Date](https://www.keypedia.com/records/crl/celltrion-inc/00dd6879-daed-432a-890e-e99047d24852)
- [CRL - Unknown Date](https://www.keypedia.com/records/crl/celltrion-inc/74e9d282-eb72-4964-ae8d-7258a3bac126)
- [483 - 2024-02-27](https://www.keypedia.com/records/483/celltrion-inc/f5ab1f32-2192-4aed-afb0-e72bdcc2519c)
- [CRL - Unknown Date](https://www.keypedia.com/records/crl/celltrion-inc/0763a33e-2365-43bd-9c70-1bdec22e4f9c)

## Related Officers

- [ Investigator ](https://www.keypedia.com/people/matthew-b-casale/e78481c6-5fbd-4723-a79c-167176395af8)

Company: https://www.keypedia.com/companies/celltrion-inc/d3991ec8-423b-4554-9d67-72bc27a8658b

Office: https://www.keypedia.com/offices/office-of-biological-products-operations-division-i/49c53dac-7724-4c8c-8708-4f5779ea69c1